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Abstract
Background: Life expectancy is increasing in Europe, yet a substantial proportion of adults still die prematurely
before the age of 70 years. We sought to estimate the joint and relative contributions of tobacco smoking,
hypertension, obesity, physical inactivity, alcohol and poor diet towards risk of premature death.
Methods: We analysed data from 264,906 European adults from the EPIC prospective cohort study, aged between
40 and 70 years at the time of recruitment. Flexible parametric survival models were used to model risk of death
conditional on risk factors, and survival functions and attributable fractions (AF) for deaths prior to age 70 years
were calculated based on the fitted models.
Results: We identified 11,930 deaths which occurred before the age of 70. The AF for premature mortality for
smoking was 31 % (95 % confidence interval (CI), 31–32 %) and 14 % (95 % CI, 12–16 %) for poor diet. Important
contributions were also observed for overweight and obesity measured by waist-hip ratio (10 %; 95 % CI, 8–12 %)
and high blood pressure (9 %; 95 % CI, 7–11 %). AFs for physical inactivity and excessive alcohol intake were 7 %
and 4 %, respectively. Collectively, the AF for all six risk factors was 57 % (95 % CI, 55–59 %), being 35 % (95 % CI,
32–37 %) among never smokers and 74 % (95 % CI, 73–75 %) among current smokers.
Conclusions: While smoking remains the predominant risk factor for premature death in Europe, poor diet,
overweight and obesity, hypertension, physical inactivity, and excessive alcohol consumption also contribute
substantially. Any attempt to minimise premature deaths will ultimately require all six factors to be addressed.
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Background
Life expectancy in all countries of Western Europe has
increased substantially over recent decades, primarily
due to important decreases in mortality rates for death
in middle age [1]. Within the European Union (EU27, 27
countries in the European Union), male age expectancy at
age 40 ranges from 71 in the Baltic countries to around 80
in Mediterranean Europe, UK, and Sweden [2]. For women
at age 40, the range is from 79 years in Bulgaria and
Romania, to 86 years in France and Spain. If we define the
age range 40–69 as ‘middle age’ and death occurring in this
range as being premature, then about 20 % of men and 11
% of women in Europe (15 countries in the European
Union, EU15) who reach the age of 40 can be expected to
die prematurely based on current mortality rates [2].
Studies of premature death require the analysis of very
large population cohorts or intervention studies with ex-
tensive baseline exposure information on major risk fac-
tors and complete mortality data. An alternative is to use
a modelling approach, such as that taken by the Global
Burden of Diseases (GBD) initiative, whereby estimates of
exposure and disease risk from multiple sources are com-
bined and used to approximate the contribution of differ-
ent exposures to overall mortality and morbidity [1]. The
GBD has estimated that, for Europe, the primary causes of
premature mortality, in order of importance, are smoking,
dietary risks, high blood pressure, high body mass index
(BMI), physical inactivity, and high alcohol consumption.
Other important factors are thought to include high chol-
esterol, high fasting plasma glucose, ambient air pollution,
and occupational risks [3, 4]. While this initiative has re-
sulted in extremely important information, and is the only
option for most populations, it has a number of limita-
tions such as the inclusion of data of variable quality from
many different sources, and the inability to adjust compre-
hensively and consistently for other mortality risk factors
that may confound the observed relationships. The GBD
modelling approach is also usually not able to provide es-
timates of absolute risk and attributable fractions for im-
portant subgroups, e.g. for smokers and non-smokers
separately, or for sets of risk factors combined.
To overcome these limitations, we have calculated es-
timates of the contribution of primary risk factors for
premature death in Europe based on individual level
data using the European Prospective Investigation into
Cancer and Nutrition (EPIC) cohort study, which in-
cludes extensive exposure data on all primary risk fac-
tors, as well as complete follow-up for vital status, from
265,000 adults in 10 European countries.
Methods
Selection of risk factors
Our primary focus was on risk factors that are modifi-
able at a personal level, which have all been consistently
associated with elevated risks of major chronic diseases
and subsequent premature death, namely smoking [4–9],
unhealthy diet [4, 10–12], high blood pressure [4, 9, 13],
overweight and obesity [4, 14–18], physical inactivity
[4, 6, 16, 19–22], and alcohol intake [23–27]. Additionally,
we considered total cholesterol to HDL ratio (TC:HDL)
[28, 29] and glycated haemoglobin (HbA1c) [4, 30–32].
Study population
EPIC is an on-going multicentre prospective cohort study
that recruited approximately 520,000 participants in 10
European countries (Denmark, France, Germany, Greece,
Italy, The Netherlands, Norway, Spain, Sweden, and the
United Kingdom) from 1992 to 2000. Approximately 70 %
were women and most were aged between 35 and 70 years
at baseline. A detailed description of the methods employed
has previously been described [33, 34]. Blood samples were
collected at baseline according to standardised procedures,
and written informed consent for the baseline data
collection and follow-up for vital status was provided
by all study participants. For this analysis we excluded
participants who were ≥ 75 or < 40 years old when recruited
(n = 62,775); participants with missing questionnaire in-
formation (n = 30,048) or blood pressure measurements
(n = 161,693); and participants with missing follow-up
information (n = 1908). This analysis therefore included
264,906 participants (172,119 women and 92,787 men)
from nine countries (as participants from Norway did
not have their blood pressure measured). We also con-
ducted sensitivity analyses including all participants
with missing blood pressure to ensure that the estimates
for the other covariates remained similar.
Diet, lifestyle and anthropometric information
At recruitment, lifestyle and dietary questionnaires were
used to obtain detailed information on all risk factors.
Participants were classified as being never, former or
current smokers at the time of interview. Diet and alco-
hol intake over the previous 12 months were assessed at
study baseline using validated country-/centre-specific
dietary questionnaires [33, 34], and alcohol intake was
converted into grams of alcohol per day (g/day) by ap-
plying empirically derived definitions of standard drinks
for each beverage and country. Both occupational and
recreational physical activity were assessed via question-
naire using a validated scoring system [35].
Weight was measured with participants not wearing
shoes to the nearest 0.1 kg; while height was measured –
dependent on the study centre – to the nearest 0.1, 0.5,
or 1.0 cm. Waist circumference was measured either at
the smallest torso circumference or at the midpoint be-
tween the lower ribs and iliac crest. Hip circumference
was measured horizontally at the level of the largest lateral
extension of the hips or over the buttocks.
Muller et al. BMC Medicine  (2016) 14:87 Page 2 of 11
Systolic (SBP) and diastolic (DBP) blood pressure was
measured on the right arms of participants while in sit-
ting positions by trained personnel at baseline. Two sep-
arate readings were performed for each participant using
a standard mercury manometer or oscillometric device,
except in Denmark and Sweden, where one single meas-
urement was taken in the supine position. To avoid any
possible “white-coat” effect, if available, the second read-
ing was used.
Finally, the EPIC Biomarkers sub-cohort of 16,775
randomly-selected participants (10,524 with complete
risk factor data for the present analysis) was used to
measure levels of circulating cholesterol (TC:HDL ratio)
and HbA1c as a marker of average plasma glucose
concentration. Total cholesterol and HDL-C levels were
measured from serum (plasma for Umea, Sweden) using
the Cobas® homogeneous enzymatic colorimetric test assay.
HbA1c was measured from red blood cell fraction using
the Tosoh (HLC-723G8) ion exchange high-performance
liquid chromatography assay.
Assessment of mortality
Data on vital status and the cause and date of death
were collected at the EPIC study centres using record
linkages with cancer registries, boards of health and
death indices, or through active follow-up. End of
follow-up was defined as the latest date of complete
follow-up for vital status, which was between 2008 and
2010 dependent on study centre.
Definition of premature mortality
We provide estimates of the contribution for various risk
factors to the risk of dying before 70 years of age, condi-
tional on surviving to age 40 years. We additionally pro-
vide these estimates for death prior to ages 65 and 75
years in Additional file 1: Table S3 and Additional file 2:
Table S4.
Statistical methods
Participants were classified as never, former, or current
smokers. Alcohol consumption was modelled using the
following categories (standard drinks/day, with a standard
drink defined as 10 g of alcohol): 0, 0–0.5, 0.5–1, 1–2, 2–
6, 6–10, and > 12 (men only). The dietary score used was
an adapted version of the WCRF/AICR score [11], includ-
ing the intakes of (1) energy dense foods/sugary drinks, (2)
plant foods (fruits/vegetables/dietary fibre), and (3) animal
foods (red and processed meat). The derived dietary score
was categorised into four groups: unhealthy, moderately
unhealthy, moderately healthy, and healthy. Full details of
dietary score derivation can be found in the Additional
file 3: Methods. Occupational and recreational physical
activity were combined and categorised into four groups
(“The Cambridge Index”) – inactive, moderately inactive,
moderately active and active. BMI was calculated as kg/m2
and categorised as < 20, 20–21.9, 22–24.9 (reference), 25–
29.9, 30–34.9, and ≥ 35. We constructed five categories of
waist-hip ratio (WHR) by splitting the distribution at its
sex-specific quintiles. Blood pressure was categorised
into clinical cut-points: normal (SBP < 120 mm Hg and
DBP < 80 mm Hg); pre-hypertension (SBP ≥ 120 mm
Hg or DBP ≥ 80 mm Hg); hypertension 1 (SBP ≥ 140 mm
Hg or DBP ≥ 90 mm Hg); and hypertension 2 (SBP ≥ 160
mm Hg or DBP ≥ 100 mm Hg) [36]. Sex-specific fourths
were created for both TC:HDL and HbA1c.
Hazard ratios (HR) and 95 % confidence intervals (CI)
for all-cause mortality were estimated using flexible
parametric survival models on the cumulative hazards
scale [37, 38], which – in addition to the HR – allow direct
estimation of the conditional cumulative hazard function,
and thus absolute risks of death. Within these models we
employed restricted cubic splines with three internal knots
to model the baseline hazard using attained age as the
time-scale. Separate models were fitted for men and
women, as well as for both sexes combined. All models
included age at baseline, smoking status, dietary score,
alcohol intake, physical activity, blood pressure, and ei-
ther BMI or WHR. Finally, we considered models that
also included the TC:HDL ratio or HbA1c in the sub-
cohort which had these measures available. We present
HRs and CIs for premature mortality estimated using
models fit to follow-up data censored at 70 years of
age. We investigated non-proportional hazards by fit-
ting interactions between covariates and the time-scale
(attained age), and the final models allowed the parameters
for smoking status to vary over time. We also examined
whether there were any important interactions between
pairs of covariates by comparing models with and without
interaction terms using the likelihood-ratio test.
Model-based survival functions and their CI were ob-
tained from fitted models at specific combinations of co-
variate values. These survival functions were conditional
on surviving until age 40 years. We also calculated at-
tributable fractions (AFs) for each covariate based on the
predicted survival functions evaluated at age 70. These
AFs rely on the comparison between the expected sur-
vival at age 70 under the following scenarios: (1) the ob-
served distribution of risk factors in the cohort and (2)
an alternative, reference (counterfactual) distribution of
risk factors corresponding to the removal of a specific
risk factor or set of risk factors. For most risk factors,
the reference distribution was simply set so each mem-
ber of the cohort was “unexposed” to the risk factor, or
in the category of the risk factor associated with the low-
est risk of death. These attributable risks thus represent
a “best-case”, in that they are calculated based on a
hypothetical reference population with risk factors re-
moved entirely. For smoking, the reference distribution
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was a cohort of never smokers. For most risk factors the
reference distribution was similarly defined, i.e. normal
blood pressure, most healthy diet, physically active, and
lowest category of WHR. For BMI, the reference distri-
bution was set to 22–25 for all participants with a BMI
above 22, and left unchanged for those with a BMI < 22.
The reference distribution for alcohol intake was a
population that drinks no more than one or two stand-
ard drinks per day. Thus, the reference distribution
removes the excess risk associated with drinking more
than two drinks per day, without removing the apparent
excess risk from consuming less than one drink per day
or abstaining. See Additional file 3: Methods for technical
details of the AF calculations. All statistical analyses were
conducted using Stata version 12.1 and R version 3.1.2.
Results
Among the 264,906 EPIC participants (172,119 women
and 92,787 men) with complete baseline and follow-up
data who were included in this analysis, we identified
11,930 premature deaths (i.e. before the age of 70) dur-
ing a median follow-up of 11.5 years. These deaths were
predominantly due to cancer (5907, 50 %) and circulatory
diseases (2580, 22 %). Survival functions for men and
women in our study sample are presented in Additional
file 4: Figure S1. Survival to age 70 was somewhat higher
in EPIC (93 % for women and 86 % for men) than that ex-
pected based on the general European population (89 %
for women and 80 % for men, calculated based on mortal-
ity rates from the EU15) [2]. After accounting for sex and
smoking status, the survival functions were similar across
all countries, with the exception of Italy and France, which
had higher survival in each of the sex/smoking strata
(Additional file 5: Figure S2). The distributions of the risk
factors are presented in Table 1. The number of partici-
pants by country and sex are presented in Additional file
6: Table S1 and the distribution of covariates by country is
presented in Additional file 7: Table S2.
Hazard ratios
The HRs for premature mortality are presented in
Table 2. After mutual adjustment for all risk factors, over
a two-fold greater risk was observed for current smokers
when compared with never smokers for both men (HR,
2.54; 95 % CI, 2.36–2.73) and women (HR, 2.14; 95 %
CI, 2.01–2.29), with former smokers having an inter-
mediate risk. When compared with the physically in-
active group, being physically very active was associated
with substantially lower mortality rates for men (HR,
0.73; 95 % CI, 0.68–0.78) and women (HR, 0.69; 95 %
CI, 0.64–0.76). Men and women with a ‘healthy’ diet had
22 % (HR, 0.78; 95 % CI, 0.69–0.88) and 25 % (HR, 0.75;
95 % CI, 0.67–0.83) lower mortality rates, respectively,
when compared with the ‘unhealthy’ diet groups. J-shaped
relationships between alcohol consumption at baseline
and mortality were observed for men and women, with
the highest mortality rates found for the highest con-
sumers (>6 drinks/day for women; HR, 1.63; 95 % CI,
1.31–2.04 and > 10 drinks/day for men; HR, 2.38; 95 % CI,
2.02–2.79) when compared with the moderate alcohol
consumption reference group (1–2 drinks per day). For
BMI (unadjusted for WHR), when compared with the
22–24.9 reference group, higher mortality rates were
observed for the extreme high (35+: men, HR, 1.77; 95 %
CI, 1.50–2.09; women, HR, 1.40; 95 % CI, 1.20–1.63) and
low (<20: men, HR, 1.76; 95 % CI, 1.54–2.01; women, HR,
1.55; 95 % CI, 1.38–1.75) BMI groups. For WHR (un-
adjusted for BMI), when the highest and lowest fifths were
compared, 39 % (HR, 1.39; 95 % CI, 1.28–1.51) and 52 %
(HR, 1.52; 95 % CI, 1.39–1.65) higher premature mortality
rates were observed for women and men, respectively.
Participants with hypertension also had higher premature
mortality rates than those with normal blood pressure
levels, with an increasing gradient for hypertension level 1
(HR, 1.17; 95 % CI, 1.09–1.25) and level 2 (HR, 1.52; 95 %
CI, 1.40–1.64).
Attributable fractions
Attributable fractions (AF) for premature mortality were
calculated overall and by sex, and also for never smokers
and current smokers separately (Table 3). Given the
monotonic association between mortality and WHR, this
was used as the primary measure of overweight and
obesity, although all results were calculated using BMI
also. The AF calculations represent “best-case” estimates
based on the hypothetical removal of risk-elevating fac-
tors from the population entirely.
The AF for smoking was 31 % (26 % among women,
37 % among men, and 56 % among current smokers
overall; Table 3). For diet and WHR the AF was 14 %
and 10 %, respectively. Overall, 9 % of premature deaths
were attributed to high blood pressure, and the AFs for
physical inactivity and high alcohol intake were 7 % and
4 %, respectively. The role of alcohol was more import-
ant among men than women (6 % vs. 2 %). When BMI
was used instead of WHR, the effect of being over-
weight/obese was less apparent, with the AF estimated
to be 3 % (Additional file 1: Table S3).
Because these risk factors co-vary to a large degree, it
is not possible to sum up the AF estimates to come to
an overall estimate. We can derive such an estimate by
removing the effect of each risk factor consecutively,
yielding a cumulative AF for a combination of risk factors.
After accounting for the fraction of premature deaths at-
tributable to smoking, an additional 10 % can be attributed
to poor diet. Beyond this, an additional 6 % were attrib-
uted to overweight and obesity (WHR), and 5 % to high
blood pressure (Table 3). Overall, 52 % of all premature
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Table 1 Baseline and covariate distributions in the EPIC cohort: overall, for premature deaths (prior to age 70 years), and by sex
All Sex
Total Premature deaths Male Female
n = 264,906 % n = 11,930 % n = 92,787 % n = 172,119 %
Age at baseline, years 40–50 67,229 25 1597 13 21,270 23 45,959 27
50–60 124,557 47 7302 61 44,441 48 80,116 47
60–70 64,640 24 3031 25 23,492 25 41,148 24
Smoking Never smoker 121,743 46 3365 28 26,462 29 95,281 55
Former smoker 79,391 30 3489 29 37,967 41 41,424 24
Current smoker 63,772 24 5076 43 28,358 31 35,414 21
Blood pressure Normal 54,935 21 1793 15 11,253 12 43,682 25
Pre-hypertension 102,263 39 4023 34 35,844 39 66,419 39
Hypertension 1 72,429 27 3711 31 30,481 33 41,948 24
Hypertension 2 35,279 13 2403 20 15,209 16 20,070 12
BMI (kg/m2) < 20 12,001 5 665 6 1447 2 10,554 6
20–21.9 30,376 11 1244 10 5443 6 24,933 14
22–24.9 (reference) 77,680 29 3127 26 24,984 27 52,696 31
25–29.9 (overweight) 103,379 39 4602 39 46,392 50 56,987 33
30–34.9 (obese) 32,270 12 1672 14 12,391 13 19,879 12
35+ (very obese) 9200 3 620 5 2130 2 7070 4
Waist-to-hip ratio
(sex-specific fifths)
1 57,336 22 1960 16 19,000 20 38,336 22
2 52,688 20 2102 18 21,985 24 30,703 18
3 59,966 23 2372 20 18,517 20 41,449 24
4 45,066 17 2200 18 14,844 16 30,222 18
5 49,850 19 3296 28 18,441 20 31,409 18
Alcohol intake (drinks/day) 0 32,826 12 1598 13 5941 6 26,885 16
0–0.5 78,871 30 3054 26 16,748 18 62,123 36
0.5–1 42,158 16 1580 13 13,255 14 28,903 17
1–2 50,904 19 2073 17 20,550 22 30,354 18
2–6 52,468 20 2741 23 29,860 32 22,608 13
> 6 (women), 6–10 (men) 6683 3 690 6 5437 6 1246 1
> 10 (men) 996 0 194 2 996 1 0 0
Diet Unhealthy 22,346 8 1746 15 12,617 14 9729 6
Moderately unhealthy 112,965 43 5792 49 48,238 52 64,727 38
Moderately healthy 77,110 29 2800 23 20,515 22 56,595 33
Healthy 52,485 20 1592 13 11,417 12 41,068 24
Physical activity Inactive 61,771 23 3155 26 18,658 20 43,113 25
Moderately inactive 88,907 34 3753 31 29,062 31 59,845 35
Moderately active 60,548 23 2531 21 22,015 24 38,533 22
Active 53,680 20 2491 21 23,052 25 30,628 18
All 10,524 100 469 100 3899 100 6625 100
Total to HDL cholesterol ratio
(sex-specific fourths)
< 3.79 (men), < 3.09 (women) 2530 24 73 16 933 24 1597 24
3.79–4.64 (men), 3.09–3.76 (women) 2531 24 96 20 921 24 1610 24
4.64–5.73 (men), 3.76–4.69 (women) 2517 24 118 25 920 24 1597 24
5.73 + (men), 4.69 + (women) 2503 24 159 34 923 24 1580 24
missing 443 4 23 5 202 5 241 4
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deaths can be attributed to these four factors. The two
remaining factors (physical activity and alcohol intake)
added an additional 5 %, resulting in a total AF of 57 %.
The AF for premature mortality for all six exposures was
74 % among current smokers (56 % smoking) and 35 %
among never smokers. The attributable fractions were
similar for deaths prior to age 65 (Additional file 2: Table
S4) and 75 years (Additional file 8: Table S5), and
remained similar in sensitivity analyses including all par-
ticipants with missing blood pressure (Additional file 9:
Table S6).
Survival curves
To estimate the effect that these risk factors can have on
expected survival at an individual level, we compared
survival curves for current smokers and non-smokers
after further stratifying by whether they had otherwise
“healthy” or “unhealthy” characteristics (Fig. 1). ‘Healthy’
was defined as a BMI of 22–25, having normal blood
pressure, being moderately physically active, eating a
healthy diet, and drinking one to two drinks per day.
“Unhealthy” was defined as a BMI of 30–35, being phys-
ically inactive, eating an unhealthy diet, being hyperten-
sive, and consuming more than two drinks per day.
Comparison of the four groups indicated that 96 % of
“healthy” non-smoking women (95 % CI, 96–97 %) and
95 % of “healthy” non-smoking men (95 % CI, 94–96 %)
could be expected to survive to 70. Conversely, only 64 %
(95 % CI, 60–67 %) and 79 % (95 % CI, 76–82 %) of smok-
ing men and women with additional unhealthy characteris-
tics, respectively, could be expected to live to this age. The
two intermediate groups, smokers with otherwise healthy
characteristics and ‘unhealthy’ non-smokers, had similar
expected survival.
Cholesterol and glycated haemoglobin
Based on the EPIC-Biomarkers sub-cohort of 10,524 in-
dividuals, including 469 premature deaths, an increased
risk of premature mortality was seen across all four cat-
egories of TC:HDL (Additional file 10: Table S7), reaching
a 63 % increase in the fourth (highest) compared with the
first (lowest) quartile. Based on this modest sample size,
the AF for TC:HDL was estimated to be 15 % (95 % CI,
7–23 %). Conversely, no apparent increase in risk was
observed for higher levels of HbA1c.
Discussion
Our analysis of the primary causes of premature death
among more than 250,000 European adults indicates that
the four major risk factors are tobacco smoking, poor diet,
obesity, and high blood pressure, which together account
for over 50 % of premature deaths. Two other risk factors,
physical inactivity and excessive alcohol consumption,
have AFs of 7 % and 4 % of premature deaths, respectively.
Our study also provides preliminary evidence for an im-
portant AF for high cholesterol levels, although the sample
size was limited.
The GBD has derived similar estimates for the role of
each exposure using an alternative modelling approach,
relying largely on published estimates of effect for each
exposure and estimates of exposure prevalence in each
population [1]. Their estimates of AFs for premature
mortality for the European population provide broadly
comparable estimates for smoking, poor diet and high
blood pressure (Table 4). However, the GBD estimates
are approximately twice as high for excessive alcohol
consumption (8 % vs. 4 %), and substantially higher for
excessive body mass (14 % vs. 3 % based on BMI). Using
WHR as a measure of obesity made the estimates more
comparable (10 % based on WHR).
There are three possible explanations for these differ-
ences. Firstly, the estimates of relative risk used in the
calculations might differ – indeed, we estimated modest
relative risks for overweight and obesity and physical in-
activity. Secondly, the distribution of the risk factors
used for the GBD computations might differ from the
distribution in EPIC which, for example, includes relatively
few very heavy consumers of alcohol or very obese partici-
pants. This is a well-known phenomenon in prospective
cohort studies, also called “healthy volunteer” effect. Fi-
nally, the reference or counterfactual distributions
used for the AF calculations might differ. For instance,
the GBD used a “theoretical minimum-risk exposure
distribution”. On the other hand, we have chosen to
not necessarily use a theoretically “optimal” exposure
distribution in all cases. For instance, using the lowest
risk category for alcohol intake or BMI would involve
an increase in alcohol intake or BMI in a proportion of
the participants. Instead, we have focused on the AF for
high alcohol intake and overweight and obesity per se.
Low reported alcohol intake in particular is associated




< 5.26 3121 30 120 26 1154 30 1967 30
5.26–5.54 (men), 5.26–5.44 (women) 2543 24 100 21 1156 30 1387 21
5.54–5.72 (men), 5.44–5.72 (women) 2354 22 96 20 619 16 1735 26
5.72 + 2399 23 142 30 934 24 1465 22
missing 107 1 11 2 36 1 71 1
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with substantially higher risk of death in EPIC, possibly
due to the influence of former drinkers who quit for
health reasons or misclassification of heavy drinkers
[23, 27, 39]. This misclassification would lead to an
underestimation of the AF for alcohol in the EPIC study,
and – assuming that the GBD estimates do not suffer
from the same problems – may explain the difference be-
tween the EPIC and GBD estimates in this case.
On an individual level, the estimated conditional sur-
vival curves suggest smoking could have a similar effect
on survival to age 70 to that of all other factors com-
bined. Men who were smokers but possessed otherwise
healthy characteristics had expected survival of 86 %,
similar to the 83 % expected survival for men with un-
healthy characteristics but who never smoked. For women,
both smokers with otherwise healthy characteristics and
Table 2 Hazard ratios and confidence intervals for death prior to age 70 years in the EPIC cohort
Overall Women Men
Model 1 Model 2 Model 1 Model 2 Model 1 Model 2
HR (95 % CI) HR (95 % CI) HR (95 % CI) HR (95 % CI) HR (95 % CI) HR (95 % CI)
Smoking status Never 1.00 1.00 1.00 1.00 1.00 1.00
Former 1.39 (1.32–1.46) 1.37 (1.30–1.43) 1.30 (1.21–1.39) 1.29 (1.20–1.38) 1.47 (1.36–1.58) 1.43 (1.32–1.54)
Smoker 2.38 (2.27–2.50) 2.36 (2.25–2.48) 2.16 (2.03–2.30) 2.14 (2.01–2.29) 2.57 (2.39–2.77) 2.54 (2.36–2.73)
Physical activity Inactive 1.00 1.00 1.00 1.00 1.00 1.00
Moderately inactive 0.78 (0.74–0.82) 0.79 (0.75–0.82) 0.78 (0.73–0.84) 0.79 (0.73–0.84) 0.77 (0.72–0.82) 0.77 (0.72–0.83)
Moderately active 0.75 (0.71–0.79) 0.75 (0.71–0.79) 0.72 (0.66–0.78) 0.72 (0.67–0.78) 0.76 (0.70–0.82) 0.77 (0.71–0.83)
Active 0.71 (0.67–0.75) 0.72 (0.68–0.76) 0.69 (0.64–0.75) 0.69 (0.64–0.76) 0.72 (0.67–0.77) 0.73 (0.68–0.78)
Diet Unhealthy 1.00 1.00 1.00 1.00 1.00 1.00
Moderately unhealthy 0.87 (0.82–0.92) 0.88 (0.83–0.93) 0.85 (0.77–0.93) 0.85 (0.77–0.93) 0.88 (0.82–0.94) 0.89 (0.83–0.95)
Moderately healthy 0.80 (0.75–0.85) 0.81 (0.76–0.87) 0.78 (0.70–0.86) 0.79 (0.71–0.87) 0.80 (0.74–0.88) 0.82 (0.75–0.90)
Healthy 0.75 (0.70–0.81) 0.77 (0.72–0.83) 0.73 (0.66–0.82) 0.75 (0.67–0.83) 0.76 (0.67–0.85) 0.78 (0.69–0.88)
Alcohol intake
(drinks/day)
0 1.58 (1.47–1.70) 1.58 (1.47–1.70) 1.46 (1.33–1.61) 1.46 (1.32–1.60) 1.90 (1.70–2.12) 1.91 (1.71–2.14)
0–0.5 1.17 (1.10–1.25) 1.18 (1.11–1.25) 1.13 (1.04–1.22) 1.13 (1.04–1.22) 1.26 (1.14–1.38) 1.27 (1.15–1.39)
0.5–1 1.00 1.00 1.00 1.00 1.00 1.00
1–2 0.97 (0.91–1.04) 0.97 (0.91–1.04) 0.98 (0.90–1.08) 0.98 (0.89–1.08) 0.97 (0.89–1.07) 0.97 (0.88–1.07)
2–6 1.07 (1.00–1.14) 1.06 (1.00–1.13) 1.16 (1.05–1.27) 1.15 (1.04–1.26) 1.04 (0.96–1.14) 1.03 (0.95–1.13)
> 6 (women), 6–10 (men) 1.51 (1.38–1.66) 1.47 (1.34–1.62) 1.72 (1.38–2.15) 1.63 (1.31–2.04) 1.48 (1.32–1.65) 1.45 (1.29–1.62)
> 10 (men) 2.47 (2.12–2.88) 2.40 (2.06–2.79) 2.43 (2.07–2.85) 2.38 (2.02–2.79)
Blood pressure Normal 1.00 1.00 1.00 1.00 1.00 1.00
Pre-hypertension 1.03 (0.97–1.09) 0.99 (0.93–1.04) 1.04 (0.96–1.11) 1.00 (0.93–1.07) 1.04 (0.95–1.14) 0.99 (0.90–1.08)
Hypertension 1 1.19 (1.12–1.26) 1.12 (1.06–1.19) 1.16 (1.07–1.26) 1.10 (1.02–1.19) 1.24 (1.13–1.37) 1.15 (1.05–1.27)
Hypertension. 2 1.56 (1.46–1.67) 1.45 (1.36–1.55) 1.50 (1.37–1.65) 1.42 (1.29–1.55) 1.63 (1.47–1.81) 1.50 (1.36–1.66)
BMI (kg/m2) < 20 1.62 (1.48–1.76) 1.47 (1.33–1.63) 1.98 (1.70–2.30)
20–21.9 1.17 (1.09–1.25) 1.10 (1.01–1.20) 1.25 (1.13–1.40)
22–24.9 (reference) 1.00 1.00 1.00
25–29.9 (overweight) 0.98 (0.94–1.03) 1.03 (0.96–1.10) 0.97 (0.91–1.03)
30–34.9 (obese) 1.16 (1.09–1.23) 1.05 (0.95–1.15) 1.26 (1.16–1.37)
35+ (very obese) 1.61 (1.47–1.76) 1.55 (1.38–1.75) 1.76 (1.54–2.01)
Waist-to-hip
ratio (fifths)
1 1.00 1.00 1.00
2 1.01 (0.95–1.07) 1.00 (0.91–1.09) 1.03 (0.95–1.13)
3 1.02 (0.96–1.08) 0.99 (0.92–1.08) 1.06 (0.97–1.15)
4 1.19 (1.11–1.26) 1.15 (1.05–1.25) 1.24 (1.13–1.36)
5 1.44 (1.36–1.53) 1.39 (1.28–1.51) 1.52 (1.39–1.65)
Estimates from flexible parametric survival models with attained age as the time-scale. Models included all listed covariates, as well as age at baseline attendance
and country of recruitment. Overall estimates are also adjusted for sex. Model 1 includes BMI, whereas Model 2 includes waist-to-hip ratio as a measure of adiposity.
Model 1 and Model 2 are otherwise identical
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unhealthy non-smokers also had similar expected survival
(92 % and 90 %, respectively). These estimates reinforce
the critical importance of smoking in terms of preventing
premature death, and suggest it is as important as the
other five major risk factors combined.
A strength of our approach is the ability to estimate
AFs for important sub-groups, such as smokers and
never smokers, and also the direct estimation of AFs for
combinations of risk allowing for their interdependence.
Interestingly, our results indicate that, for both current
and never smokers, an equivalent proportion of prema-
ture deaths can be attributed to poor diet, hypertension,
overweight and obesity, and physically inactivity.
The principal limitation of our study is the relatively
small number of participants with available cholesterol
and HbA1c measurements, leading to imprecise esti-
mates of relative risks, prevalence, and AF for these fac-
tors. Further, given that all exposures were assessed only
once at recruitment to the study, we could not assess
the potential effects of changing exposures over time,
such as quitting smoking, gaining or losing weight, or
increasing physical activity. As such, our estimated AFs
and survival functions cannot be interpreted as the ex-
pected effects on mortality if individuals were to change
their lifestyle or diet, but rather reflect comparisons of
individuals with a given, constant pattern of exposures,
or hypothetical scenarios in which no-one in the popula-
tion is exposed to a given risk factor. Similarly, with only
one assessment of exposure we cannot assess the poten-
tial effects of measurement error, which are unlikely to
be equal across the six factors (e.g. BMI and blood pres-
sure are subject to only modest measurement error, es-
pecially compared with self-reported diet and physical
activity), and can lead to under- or overestimates of the
risk associated with specific risk factors. Finally, the
participants in EPIC are not representative of the gen-
eral European population and may have a different dis-
tribution of risk factors than other target populations.
Table 3 Population attributable fractions of deaths prior to age 70 given the distribution of covariates in the EPIC cohort, using
waist-to-hip ratio to assess for obesity
All participants Never smokers Current smokers
Covariatea Overallb Cumulativec Overallb Cumulativec Overallb Cumulativec
Women and Men Smoking 0.31 (0.31–0.32) 0.31 (0.31–0.32) – – 0.56 (0.55–0.56) 0.56 (0.55–0.56)
Diet 0.14 (0.12–0.16) 0.41 (0.39–0.43) 0.12 (0.10–0.14) 0.12 (0.10–0.14) 0.16 (0.13–0.18) 0.63 (0.62–0.64)
Overweight and obesity (WHR) 0.10 (0.08–0.12) 0.47 (0.45–0.49) 0.10 (0.08–0.11) 0.21 (0.18–0.23) 0.10 (0.08–0.12) 0.67 (0.66–0.68)
High blood pressure 0.09 (0.07–0.11) 0.52 (0.50–0.54) 0.09 (0.08–0.11) 0.28 (0.25–0.31) 0.08 (0.07–0.10) 0.70 (0.69–0.71)
Physical inactivity 0.07 (0.05–0.09) 0.56 (0.54–0.57) 0.08 (0.06–0.10) 0.34 (0.31–0.36) 0.07 (0.05–0.09) 0.72 (0.71–0.74)
Alcohol intake 0.04 (0.03–0.04) 0.57 (0.55–0.59) 0.02 (0.01–0.02) 0.35 (0.32–0.37) 0.05 (0.04–0.06) 0.74 (0.73–0.75)
Combined 0.57 (0.55–0.59) 0.35 (0.32–0.37) 0.74 (0.73–0.75)
Women Smoking 0.26 (0.25–0.26) 0.26 (0.25–0.26) – – 0.55 (0.54–0.55) 0.55 (0.54–0.55)
Diet 0.14 (0.11–0.16) 0.36 (0.33–0.38) 0.12 (0.09–0.15) 0.12 (0.09–0.15) 0.16 (0.13–0.19) 0.62 (0.60–0.63)
Overweight and obesity (WHR) 0.07 (0.05–0.09) 0.40 (0.38–0.43) 0.07 (0.05–0.09) 0.18 (0.15–0.22) 0.07 (0.05–0.10) 0.65 (0.63–0.66)
High blood pressure 0.10 (0.07–0.12) 0.46 (0.43–0.48) 0.11 (0.08–0.13) 0.27 (0.23–0.30) 0.09 (0.07–0.11) 0.68 (0.66–0.70)
Physical inactivity 0.06 (0.03–0.09) 0.49 (0.46–0.52) 0.07 (0.03–0.10) 0.32 (0.28–0.35) 0.06 (0.03–0.09) 0.70 (0.68–0.72)
Alcohol intake 0.02 (0.01–0.03) 0.50 (0.47–0.53) 0.01 (0.01–0.02) 0.32 (0.28–0.36) 0.03 (0.02–0.04) 0.71 (0.69–0.72)
Combined 0.50 (0.47–0.53) 0.32 (0.28–0.36) 0.71 (0.69–0.72)
Men Smoking 0.37 (0.35–0.38) 0.37 (0.35–0.38) – – 0.57 (0.56–0.57) 0.57 (0.56–0.57)
Diet 0.13 (0.09–0.17) 0.45 (0.43–0.48) 0.13 (0.09–0.17) 0.13 (0.09–0.17) 0.14 (0.10–0.18) 0.63 (0.61–0.65)
Overweight and obesity (WHR) 0.13 (0.11–0.16) 0.53 (0.50–0.55) 0.12 (0.09–0.14) 0.23 (0.19–0.27) 0.13 (0.11–0.16) 0.69 (0.67–0.70)
High blood pressure 0.08 (0.05–0.12) 0.57 (0.54–0.60) 0.08 (0.05–0.12) 0.29 (0.25–0.34) 0.07 (0.04–0.11) 0.71 (0.69–0.73)
Physical inactivity 0.07 (0.05–0.10) 0.60 (0.57–0.63) 0.07 (0.05–0.10) 0.35 (0.30–0.39) 0.07 (0.05–0.10) 0.74 (0.72–0.75)
Alcohol intake 0.06 (0.05–0.07) 0.63 (0.60–0.65) 0.04 (0.02–0.05) 0.37 (0.32–0.41) 0.07 (0.06–0.09) 0.76 (0.74–0.77)
Combined 0.63 (0.60–0.65) 0.37 (0.32–0.41) 0.76 (0.74–0.77)
aAttributable fractions were calculated based on the difference in expected cumulative risk given the observed covariate distributions in EPIC and the expected
cumulative risk under the following scenarios. Smoking: A population of never smokers. Diet: A population of people in the healthy category. Blood pressure: A
population of people with normal blood pressure. High alcohol intake: A population who drink at most 1–2 drinks per day. Physical activity: A population of
people in the active category. Overweight and obesity: A population of people with WHR below the lowest sex-specific quintile. These attributable risks thus
represent a “best-case”, in that they are calculated based on a hypothetical reference population with risk factors removed entirely
bEstimated using predictions from a model mutually adjusted for all listed covariates as well as age at baseline. Attributable fractions are based on modifying one
covariate at a time, with the distribution of the remaining covariates left as observed in EPIC
cThe cumulative attributable fraction after the sequential addition of each covariate
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In addition to the participants not being a representa-
tive sample of any population at baseline, during the
follow-up period, the participants have aged, so esti-
mates presented here do not strictly represent the age
group 40 to 70.
We choose to include individuals who reported a
prevalent chronic disease condition at baseline (e.g.
diabetes, heart disease, angina, or a previous diagnosis
of cancer), as such a sample would be more represen-
tative of the underlying population. Excluding the 7 %
of the cohort who did report a prevalent chronic dis-
ease at baseline did not have any substantial effect on
our results. As an additional sensitivity analysis to
evaluate the possibility of sick individuals changing
their lifestyle habits relatively recently prior to inter-
view, we also excluded the first 4 years of follow-up.
Again, this exclusion did not substantially affect the
results.
Conclusions
In summary, we used individual level data from a large
European prospective cohort study to estimate the relative
contributions of various factors to premature mortality
both on the population level and the individual level.
While smoking remains the predominant risk factor for
premature mortality in Europe, poor diet, obesity, and
hypertension also have a substantial additional effect. We
also provided an estimate of the incidence of death prior
to age 70 years that could be expected among an other-
wise healthy non-smoking population (about 4 %). Our
results indicate that it is of public health importance to
persist and extend the fight against smoking as well as
to promote healthy behaviour, including better diet,
avoidance of overweight/obesity, physical activity, and
blood pressure and blood lipid control with the aim of
minimising premature mortality.
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Fig. 1 Model-based survival curves by smoking status and other individual factors. “Healthy” participants are those with a body mass index (BMI)
of 22–25 who are moderately active, have normal blood pressure, eat a healthy diet, and drink one to two drinks per day. “Unhealthy”
participants are those with a BMI of 30–35 who are inactive, hypertensive, eat an unhealthy diet, and consume more than two drinks per day
Table 4 Comparison of population attributable fractions
(%, 95 % CI) from the Global Burden of Diseases analysis with
those from the present EPIC analysis
GBD EPIC
Tobacco smoking 25 (22–27) 31 (31–32)
Dietary risks 23 (21–26) 14 (12–16)
High blood pressure 15 (13–17) 9 (7–11)
High body mass index 14 (12–15) 3 (2–5)
High waist-to-hip ratio – 10 (8–12)
Physical inactivity and low physical activity 9 (8–11) 7 (5–9)
High alcohol use 8 (7–9) 4 (3–4)
Estimates from the GBD are taken from the website http://vizhub.healthdata.org/
gbd-compare. They are the estimated attributable fractions for death in Western
Europe for the age range 50–69 years for each risk factor
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